- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06750796
The Half Swaddling Application on Infant Sleep Routine, Maternal Sleep Quality, Depression (Half swaddling)
December 26, 2024 updated by: Hatice Kahyaoglu Sut, Tanta University
The Effect of Half Swaddling Application on Infant Sleep Routine, Maternal Sleep Quality and Postpartum Depression in Term Infants
In this prospective controlled study, it was aimed to examine the effects of half swaddling in term infants on infant sleep routine, maternal sleep quality and postpartum depression.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
In this prospective controlled study, it was aimed to examine the effects of half swaddling in term infants on infant sleep routine, maternal sleep quality and postpartum depression.
half swaddling; Half swaddling applied to a newborn baby makes the baby feel completely safe as if they are still in the womb.
After laying the soft fabric or baby blanket, it will be placed in the supine position.
It is swaddling in a way that does not restrict the movement of the baby's arms and legs too much.
n=128 (64=control, 64=half swaddling group) mothers and babies who volunteered to participate in the study will be randomized into two groups as case and control.
In the half stock group; From the 1st to the 3rd month, half swaddling will be done 15 minutes before each sleep during the day.
0 (first meeting), 1, 2 and 3 months will be interviewed by phone for follow-up purposes.
Study Type
Interventional
Enrollment (Estimated)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hatice Kahyaoglu Sut, 1.
- Phone Number: +90 05337662979
- Email: haticesut@yahoo.com
Study Locations
-
-
None Selected
-
Edirne, None Selected, Turkey, 22030
- Recruiting
- Trakya University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-45 years old,
- Term birth (single birth over 37 weeks),
- After an uncomplicated pregnancy process, the delivery was completed by normal vaginal or cesarean delivery method,
- Not using cigarettes, alcohol and stimulants,
- BMI<30,
- Not working on night shift,
- Stable vital signs,
- Those who have not received infertility treatment,
- Do not have a chronic disease (such as hypertension, diabetes mellitus),
- Not experiencing serious depression, anxiety and stress,
- Not having any organic or non-organic disease that can cause cognitive impairment (such as Delirium, Dementia, Intellectual Retardation, etc.),
- No serious maternal complications,
- Mothers who volunteered to participate in the study will be included in the study.
For baby;
- Birth weight over 2500 g,
- Stable vital signs,
- APGAR score above 7,
- No serious neonatal complications,
- Midwives without congenital malformations will be included in the study.
Exclusion Criteria:
- under 18 years old,
- Preterm birth (under 37 weeks and/or multiple births),
- Incomplete delivery by normal vaginal or cesarean delivery method after a complicated pregnancy process,
- Using cigarettes, alcohol and stimulants,
- BMI>30,
- Working night shift,
- No stable vital signs,
- Having received infertility treatment,
- Having a chronic disease (such as hypertension, diabetes mellitus),
- Experiencing severe depression, anxiety and stress,
- Having any organic or non-organic disease that can cause cognitive impairment (such as Delirium, Dementia, Intellectual Retardation, etc.),
- Serious maternal complication,
- Mothers who do not volunteer to participate in the study will not be included in the study.
For baby;
- Birth weight of 2500 g and below,
- No stable vital signs,
- APGAR score below 7,
- Serious neonatal complication,
- Babies with congenital malformations will not be included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control group
The group that will not be treated with half swaddling
|
Half swaddling application in term babies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Follow-up telephone interview will be conducted at 0 (first interview), 1st, 2nd and 3rd months
Time Frame: Postpartum first 3 months
|
Postpartum first 3 months
|
|
Pittsburgh Sleep Quality Index
Time Frame: up to 3 months
|
up to 3 months
|
|
Edinburgh Postnatal Depression Scale
Time Frame: up to 3 months
|
up to 3 months
|
|
Short Infant Sleep Routine Questionnaire
Time Frame: up to 3 months
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 18, 2023
Primary Completion (Estimated)
June 15, 2025
Study Completion (Estimated)
December 15, 2025
Study Registration Dates
First Submitted
November 19, 2024
First Submitted That Met QC Criteria
December 26, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 26, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Prospective controlled study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
For data privacy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Newborn
-
Centre Hospitalier Sud FrancilienCompleted
-
Acibadem UniversityRecruitingInfant, NewbornTurkey (Türkiye)
-
Abbott NutritionInstitute of Child HealthCompleted
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenCompleted
-
University of RochesterThe Commonwealth Fund; Academic Pediatric AssociationCompleted
-
University Hospital, Clermont-FerrandRecruiting
-
Federal State Budget Institution Research Center...Recruiting
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Ataturk UniversityMSc Elif Simay KOÇCompleted
-
Comenius UniversityActive, not recruitingInfant, NewbornSlovakia
Clinical Trials on The Half Swaddling Application
-
Akdeniz UniversityCompletedPain | Premature | PretermTurkey
-
Yonsei UniversityCompletedGeneral AnesthesiaKorea, Republic of
-
University Hospital, Basel, SwitzerlandCompleted
-
Hopital FochCompleted
-
Dr. Tamsin BrownCompleted
-
E.BadiavasUnited States Department of DefenseCompleted
-
Assiut UniversityNot yet recruitingAdherence, Medication | Bronchial Asthma
-
Birken AGCompletedAccelerating the Epithelialization of Split Thickness Skin GraftGermany
-
Bayero University Kano, NigeriaCompleted
-
American British Cowdray Medical CenterUnknown